Drug Trial Radar · NCT07176949
Early-Onset Myopia Intervention Project
Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
508
Planned (sponsor's estimate)
Start
Jun 1, 2025
Primary completion
Jun 1, 2027
Study completion May 31, 2028
Sponsor
- Lead sponsor
- Shanghai Eye Disease Prevention and Treatment CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 16, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 3 years, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.
Conditions
- Myopia
- Pre-myopia
Interventions
0.01% atropine eye dropsDrug
Participants will use 0.01% atropine eyedrops nightly for myopia control.
0.05% atropine eye dropsDrug
Participants will use 0.05% atropine eyedrops nightly for myopia control.
Spectacle lenses with highly aspherical lensletsDevice
These are a special type of eyeglass lenses designed primarily to slow down the progression of myopia (nearsightedness) in children. The center of the lens provides a clear correction for distance vision, just like regular glasses. The surrounding area contains hundreds of tiny, invisible, and highly aspherical (complex curved) microlenses. These microlenses create a special optical effect. While the child looks straight ahead clearly, peripheral light rays are focused in front of the retina. This is called "myopic defocus." Research suggests that this myopic defocus signal helps to control the excessive elongation of the eyeball, which is the main cause of myopia getting worse.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in cycloplegic spherical equivalenceTime frame: 2 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.